Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/16/2025

Management of Delayed Ejaculation

Definition and Diagnosis

  • Delayed ejaculation (DE) is defined as a consistent, bothersome inability to achieve ejaculation or excessive latency despite adequate stimulation and desire to ejaculate, with lifelong DE present since sexual debut and acquired DE developing after a period of normal ejaculatory function, as established by the American Urological Association 1
  • Clinical significance of DE is typically established when ejaculation takes longer than 25-30 minutes, sexual activity ceases due to fatigue or futility, or the condition causes personal or relationship distress, according to the American Urological Association 1
  • Anejaculation, a specific type of ejaculatory dysfunction, is defined as the absence or lack of ejaculation despite normal sexual arousal and stimulation, and can be classified into several types, including retrograde ejaculation, impaired sperm emission into the urethra, and aspermatism/anorgasmic anejaculation, with various causes such as spinal cord injury, multiple sclerosis, peripheral neuropathy, and diabetes mellitus 1
  • Diagnosis of anejaculation and DE requires a detailed sexual history, physical examination, laboratory tests (including morning testosterone levels and post-ejaculation urinalysis), and a focused neurological examination, genital and prostate examination, and assessment for signs of hormonal disorders 1, 2

Treatment Approaches

  • Referral to a mental health professional with expertise in sexual health is a primary consideration in the management of DE, and combination approaches, including psychological and pharmacological interventions, may be more effective than either alone, as suggested by the American Urological Association 1
  • Pharmacological options for delayed ejaculation/anejaculation include medications such as:

    Medication Dosage Timing
    Pseudoephedrine 60-120 mg 120-150 minutes before sex
    Ephedrine 15-60 mg 1 hour before sex
    Midodrine 5-40 mg 30-120 minutes before sex
    Oxytocin 24 IU intranasal/sublingual During sexual activity
    Bethanecol 20 mg daily -
    Yohimbine 5.4 mg three times daily -
    Cabergoline 0.25-2 mg twice weekly -
    Imipramine 25-75 mg daily -

    1

  • Testosterone therapy may be considered if total morning testosterone is <300 ng/dL, unless contraindicated, as recommended by the National Comprehensive Cancer Network 3
  • SSRIs (paroxetine, sertraline, citalopram, fluoxetine) dosed daily or clomipramine dosed on-demand may help with ejaculation issues, as suggested by the National Comprehensive Cancer Network and The Journal of Urology 3, 1

Lifestyle Modifications and Additional Interventions

  • Lifestyle modifications, such as smoking cessation, weight loss, increasing physical activity, and avoiding excess alcohol, as well as sexual technique modifications and vibratory therapy, can be beneficial, as recommended by the National Comprehensive Cancer Network 3
  • Modifying sexual positions or practices to increase stimulation, improving communication about sexual needs between partners, and considering vibratory therapy to enhance arousal, as well as pelvic physical therapy (pelvic floor muscle training) to improve sexual function, can also be helpful 3, 4
  • Partner involvement in evaluation and treatment may improve outcomes, as suggested by the American Urological Association 1

Guideline Recommendations and Considerations

  • The American Urological Association (AUA) guidelines recommend treating comorbid erectile dysfunction if present, and determining if delayed ejaculation began after starting specific medications, assessing if it occurs with all sexual activities or only certain ones, and ruling out underlying causes such as hormonal factors, neurological conditions, medication side effects, and psychological factors 1
  • The National Comprehensive Cancer Network recommends evaluating response after 4-12 weeks of any intervention and adjusting treatment based on response, with partner involvement in evaluation and treatment potentially improving outcomes 3
  • Age consideration is important, as ejaculatory dysfunction is increasingly common with age and may require more comprehensive management, according to the American Urological Association 1
  • Surgical interventions should be avoided as they are considered experimental, and treatment success varies significantly between individuals, as recommended by patient education guidelines 1